Arkolith/Insider Trading/CLYM/Form 4

Kolchinsky Peter

Director, 10% OwnerClimb Bio, Inc. (CLYM) · full profile →Form 4 · filed Dec 15, 2025
Net Buying
Open-Market Buys
$755K
Open-Market Sells
$0
Net Open-Market Flow
$755K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Buy(P)101K$2.86$290K3.4M
Dec 11, 2025Buy(P)213K$2.18$465K3.3M
Dec 11, 2025Disposed to issuer(D)20.4M—$03.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2025Grant(A)20.4M——20.4M

Transaction Codes

P
Open-market purchase
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000616) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML